Xclor Powder for Suspension 125 mg/5 ml
Xclor Powder for Suspension 125 mg/5 ml Uses, Dosage, Side Effects, Food Interaction and all others data.
| Trade Name | Xclor Powder for Suspension 125 mg/5 ml |
| Generic | Cefaclor Monohydrate |
| Weight | 125 mg/5 ml |
| Type | Powder for Suspension |
| Therapeutic Class | Second generation Cephalosporins |
| Manufacturer | Orion Pharma Ltd. |
| Available Country | Bangladesh |
| Last Updated: | October 19, 2023 at 6:27 am |
Uses
Cefaclor is indicated in the treatment of the following infections: Respiratory tract infections, including pneumonia, bronchitis, caused by Streptococcus pneumoniae, Haemophilus influenzae, and Streptococcus pyogenes Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae, Staphylococci, and Streptococcus pyogenes ... Read moreDosage
Xclor Powder for Suspension 125 mg/5 ml dosage
Capsule: Adult dose: The usual dose is 250 mg every 8 hourly. For severe infections or those caused by less susceptible organisms, doses may be doubled with a maximum dosage of 4 g/day. In case of β-hemolytic Streptococcal infections, therapy should be administered for at least 10 days.Powder for suspension & Pediatric drops: Children: The usual daily dosage for paediatric patients over 1 month is 20 mg/kg/day in divided doses every 8 hours. In serious infections such as otitis media and infections caused by less susceptible organisms, 40 mg/kg/day are recommended, with a maximum dosage of 1 g/day. Safety and effectiveness of Cefaclor for use in infants less than 1 month of age have not been established.<1 year (9 kg): Powder for suspension: ½ tsp three times daily Pediatric drops: 0.625 ml three times daily 1-5 years (9 kg-18 kg): Powder for suspension: 1 tsp three times daily Pediatric drops: 1.25 ml three times daily Over 5 years: Powder for suspension: 2 tsp three times daily In renal impairment: Cefaclor may be administered in the presence of impaired renal function. Dose adjustments for patients with moderate or sever renal impairment are not usually required.In patients undergoing haemodialysis: Haemodialysis shortens serum half-life by 25-30%. In patients undergoing haemodialysis, a predialysis loading dose of 250 mg-1 g is recommended. A maintaining dose of 250-500 mg every 6 hourly during interdialytic period may be used.Geriatric use: Clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.Side Effects
Gastro-intestinal symptoms may occur include diarrhea, nausea and vomiting in some patients receiving Cefaclor. As with some penicillins and some other Cephalosporins, transient hepatitis and cholestatic jaundice have been reported rarely. Fever, abdominal pain, superinfection, renal dysfunction, toxic nephropathy, hemorrhage, elevated LDH and pancytopenia may occur.Precaution
Prescribing Cefaclor in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.Prolonged use of Cefaclor may result in the overgrowth of nonsusceptible organisms. If superinfection occurs during therapy, appropriate measures should be taken. As with other β-lactam antibiotics, the renal excretion of Cefaclor is inhibited by Probenecid. Antibiotics, including Cephalosporins, should be prescribed with caution in individuals with a history of gastrointestinal disease, particularly colitis.Before therapy with Cefaclor is instituted, careful inquiry should be made to determine whether the patient has had previous hypersensitivity reactions to Cefaclor, Cephalosporins, Penicillins or other drugs. If this product is to be given to penicillin-sensitive patients, caution should be exercised. Cefaclor should be administered cautiously to any patient who has demonstrated some form of allergy, particularly to drugs.Interaction
Cefaclor may show a false-positive reaction for glucose in the urine with tests that use Benedict's solution, Fehling's solutions. When Cefaclor and oral anticoagulants were administered concomitantly there have been reports of increased anticoagulant effect and there have been rare reports of increased prothrombin time, with or without clinical bleeding, in patients receiving Cefaclor and anticoagulants (Warfarin) concomitantly. It is recommended that in such patients, regular monitoring of prothrombin time should be considered, with adjustment of dosage if necessary.Pregnancy & Breastfeeding use
There are no adequate and well-controlled studies in pregnant women. This drug should be used during pregnancy only if clearly needed. Small amounts of Cefaclor have been detected in mother's milk. The effect on nursing infants is not known. Caution should be exercised when Cefaclor is administered to a nursing woman.Contraindication
Cefaclor is contraindicated in patients with known allergy to the Cephalosporin group of antibiotics.Acute Overdose
The toxic symptoms following an overdose of Cefaclor may include nausea, vomiting, epigastric distress, and diarrhea.Storage Condition
Store at room temperature and protect from light. After reconstitution the suspension can be used within 7 days if kept at room temperature and within 14 days if kept in refrigerator (2-8°C). Always keep the bottle tightly closed.Innovators Monograph
You find simplified version here Xclor Powder for Suspension 125 mg/5 ml
